ES2074085T3 - Precursor de la glicoproteina de envolvente del retrovirus hiv-2 y antigenos emparentados. - Google Patents

Precursor de la glicoproteina de envolvente del retrovirus hiv-2 y antigenos emparentados.

Info

Publication number
ES2074085T3
ES2074085T3 ES89401617T ES89401617T ES2074085T3 ES 2074085 T3 ES2074085 T3 ES 2074085T3 ES 89401617 T ES89401617 T ES 89401617T ES 89401617 T ES89401617 T ES 89401617T ES 2074085 T3 ES2074085 T3 ES 2074085T3
Authority
ES
Spain
Prior art keywords
hiv
glycoprotein precursor
retrovirus envelope
separated antigens
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89401617T
Other languages
English (en)
Inventor
Luc Montagnier
Ara Hovanessian
Anne Laurent
Bernard Krust
Marie-Anne Rey
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Pasteur
Original Assignee
Institut Pasteur
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR8807817A external-priority patent/FR2632644B1/fr
Application filed by Institut Pasteur filed Critical Institut Pasteur
Application granted granted Critical
Publication of ES2074085T3 publication Critical patent/ES2074085T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—RNA viruses
    • C07K16/112—Retroviridae (F), e.g. leukemia viruses
    • C07K16/114—Lentivirus (G), e.g. human immunodeficiency virus [HIV], feline immunodeficiency virus [FIV] or simian immunodeficiency virus [SIV]
    • C07K16/1145—Env proteins, e.g. gp41, gp110/120, gp160, V3, principal neutralising domain [PND] or CD4-binding site
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

LA PROTEINA GP300 ANTIGENICA SE CARACTERIZA POR: - TENER UN PESO MOLECULAR (PK) DE UNOS 300 KD; - LA ASOCIACION DE DOS UNIDADES DE UNA GLUCOPROTEINA GP 140 PRECURSOR PRINCIPAL DE LA GLUCOPROTEINA DE ENVOLTURA GP125 CODIFICADA POR EL GEN ENV DEL GENOMA DE UN RETROVIRUS HUMANO HIV-2 SUSCEPTIBLE DE PROVOCAR UN SLA O UN SIDA O LA PROTEINA DE UN RETROVIRUS QUE CRECE INMUNOLOGICAMENTE CON UNOS ANTICUERPOS DIRIGIDOS CONTRA DICHA PROTEINA GP300 DEL RETROVIRUS HIV-2.
ES89401617T 1988-06-09 1989-06-09 Precursor de la glicoproteina de envolvente del retrovirus hiv-2 y antigenos emparentados. Expired - Lifetime ES2074085T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20434688A 1988-06-09 1988-06-09
FR8807817A FR2632644B1 (fr) 1988-06-10 1988-06-10 Antigenes precurseurs des glycoproteines d'enveloppe d'un retrovirus humain hiv-2 et antigenes presentant une parente immunologique avec ces derniers. preparation de ces antigenes. application au diagnostic

Publications (1)

Publication Number Publication Date
ES2074085T3 true ES2074085T3 (es) 1995-09-01

Family

ID=26226719

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89401617T Expired - Lifetime ES2074085T3 (es) 1988-06-09 1989-06-09 Precursor de la glicoproteina de envolvente del retrovirus hiv-2 y antigenos emparentados.

Country Status (9)

Country Link
EP (1) EP0354072B1 (es)
JP (1) JP3093763B2 (es)
AT (1) ATE122236T1 (es)
CA (1) CA1341488C (es)
DE (1) DE68922540T2 (es)
DK (1) DK175668B1 (es)
ES (1) ES2074085T3 (es)
HK (1) HK167295A (es)
PT (1) PT90800B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005078443A1 (en) * 2004-02-13 2005-08-25 Inverness Medical Switzerland Gmbh Determination of infection by the immune response to a carbohydrate moiety

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987002892A1 (en) * 1985-11-14 1987-05-21 President And Fellows Of Harvard College T-lymphotrophic virus
EP0269520A3 (fr) * 1986-11-21 1988-08-24 Institut Pasteur Rétrovirus du type HIV-2 susceptible de provoquer le sida, et ses constituants antigéniques et nucléiques
JP2948823B2 (ja) * 1987-01-16 1999-09-13 アンステイテユ・パストウール ヒト免疫不全レトロウィルス（ｈｉｖ）関連抗原性ペプチド、そのウィルス感染の検出及びワクチンへの使用

Also Published As

Publication number Publication date
PT90800B (pt) 1994-11-30
JP3093763B2 (ja) 2000-10-03
DE68922540T2 (de) 1995-10-05
JPH02119791A (ja) 1990-05-07
ATE122236T1 (de) 1995-05-15
DK284389D0 (da) 1989-06-09
DK284389A (da) 1989-12-10
DK175668B1 (da) 2005-01-10
PT90800A (pt) 1989-12-29
DE68922540D1 (de) 1995-06-14
HK167295A (en) 1995-11-03
EP0354072A1 (fr) 1990-02-07
EP0354072B1 (fr) 1995-05-10
CA1341488C (fr) 2005-08-30

Similar Documents

Publication Publication Date Title
DE68927348D1 (de) Künstlicher impfstoff gegen aids-virus
DE3855947D1 (de) Peptide mit den immunologischen Eigenschaften von HIV-2
NO881719D0 (no) Syntetisk hiv-2-antigen.
DE3871673D1 (de) Arzneimittel fuer den bereich der mundhoehle.
ES2100240T3 (es) Bacteriofagos modificados mediante ingenieria genetica y vacunas que los contienen.
DE3885431D1 (de) Expression der viral kodierten Protease P2A des HRV2.
ATE47524T1 (de) Hundeparvovirus-impfstoffe.
DK641787A (da) Virusvektor, der koder for et glycoprotein fra det virus, der er ansvarligt for aids, vaccine, der omfatter virusvektoren eller glycoproteinet, samt antistof mod glycoproteinet
ES2074085T3 (es) Precursor de la glicoproteina de envolvente del retrovirus hiv-2 y antigenos emparentados.
ES2058259T5 (es) Antigenos sinteticos para la deteccion de enfermedad relacionada con sida causada por lav-2.
FR2676071B1 (fr) Nouveau variant gp160 non-clivable, soluble, de forme hybride.
ES2085908T3 (es) Antigenos de la glucoproteina transmembranica de cubierta de un retrovirus humano del tipo hiv-2 (antigenos que presentan entre ellos un parentesco inmunologico).
MY104530A (en) Nonreplicating recombinant-made retroviral particles useful as anti-viral agents and as immunogens for pro- phylaxis and therapy against human retroviruses.
ATE132034T1 (de) Künstliche virushüllen
FI881123A7 (fi) Human Immunodeficiency Viruksen (HIV) inaktivoiminen proteiinipitoisissa liuoksissa fenolilla.
ATE153379T1 (de) Expression von proteinsüssmitteln in hefe
DK0494317T4 (da) SIV cpz-ant-retrovirus og anvendelse deraf
ATE85215T1 (de) Antivirales therapeutikum.
IT1244529B (it) Peptidi sintetici atti a potenziare l'infettivita' del virus hiv-1
FR2614025B1 (fr) Peptides susceptibles d'etre reconnus par des anticorps induits contre des retrovirus d'immunodeficience humaine (virus hiv) leurs applications au diagnostic des infections dues a certains de ces virus et, le cas echeant, a la vaccination contre le sida
ATE87827T1 (de) Anti-hiv-wirkung von bu-3608.
NO881501L (no) Rekombinante htlv-111-proteiner og anvendelser av disse.
SU1578880A1 (ru) Пептид, обладающий защитным действием против вируса ящура штамма a
RO87894B1 (ro) Compozitie de respingere a insectelor

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 354072

Country of ref document: ES